Foresite Capital Management III, LLC current holdings: USA Other Stocks
Foresite Capital Management III, LLC reported $0.19 billion in shares no fund filing gives a ticker for, so this site has no page for them (listed in the US), 14 positions, in its Form 13F for the quarter ended 2016-09-30; the largest are Aerie Pharmaceuticals, Inc., Alder BioPharmaceuticals, Inc., WAVE Life Sciences Ltd..
- Aerie Pharmaceuticals, Inc.: Country of operation —; Class COM; Shares 1,697,884; Value $64,078,000.
- Alder BioPharmaceuticals, Inc.: Country of operation —; Class COM; Shares 1,585,683; Value $51,963,000.
- WAVE Life Sciences Ltd.: Country of operation —; Class SHS; Shares 727,496; Value $23,622,000.
- Aimmune Therapeutics, Inc.: Country of operation —; Class COM; Shares 935,020; Value $14,025,000.
Form 13F-HR as filed (SEC CIK 1645157): quarter ended 2016-09-30, filed 2016-11-14. The manager files one row per sub-manager; rows for the same security, class and put/call are added together.
| Stock | Country of operation | Class | Shares | Value | Quarter end | Filed |
|---|
Aerie Pharmaceuticals, Inc.
CUSIP 00771V108 | | COM | 1,697,884 | $64,078,000 | 2016-09-30 | 2016-11-14 |
|---|
Alder BioPharmaceuticals, Inc.
CUSIP 014339105 | | COM | 1,585,683 | $51,963,000 | 2016-09-30 | 2016-11-14 |
|---|
WAVE Life Sciences Ltd.
CUSIP Y95308105 | | SHS | 727,496 | $23,622,000 | 2016-09-30 | 2016-11-14 |
|---|
Aimmune Therapeutics, Inc.
CUSIP 00900T107 | | COM | 935,020 | $14,025,000 | 2016-09-30 | 2016-11-14 |
|---|
Global Blood Therapeutics, Inc.
CUSIP 37890U108 | | COM | 455,590 | $10,501,000 | 2016-09-30 | 2016-11-14 |
|---|
NanoString Technologies, Inc.
CUSIP 63009R109 | United States | COM | 485,600 | $9,702,000 | 2016-09-30 | 2016-11-14 |
|---|
Momenta Pharmaceuticals, Inc.
CUSIP 60877T100 | | COM | 595,513 | $6,962,000 | 2016-09-30 | 2016-11-14 |
|---|
Epizyme, Inc.
CUSIP 29428V104 | | COM | 611,777 | $6,020,000 | 2016-09-30 | 2016-11-14 |
|---|
Zafgen, Inc.
CUSIP 98885E103 | | COM | 537,495 | $1,779,000 | 2016-09-30 | 2016-11-14 |
|---|
Lipocine Inc.
CUSIP 53630X104 | | COM | 302,640 | $1,350,000 | 2016-09-30 | 2016-11-14 |
|---|
Audentes Therapeutics, Inc.
CUSIP 05070R104 | | COM | 66,553 | $1,185,000 | 2016-09-30 | 2016-11-14 |
|---|
Orexigen Therapeutics, Inc.
CUSIP 686164104 | | COM | 254,257 | $844,000 | 2016-09-30 | 2016-11-14 |
|---|
Syros Pharmaceuticals, Inc.
CUSIP 87184Q107 | | COM | 60,000 | $832,000 | 2016-09-30 | 2016-11-14 |
|---|
BioDelivery Sciences International, Inc.
CUSIP 09060J106 | | COM | 47,158 | $127,000 | 2016-09-30 | 2016-11-14 |
|---|
Similar Firms
| Firm Name | Country | 13F Value | Holdings |
|---|
| Not available yet |